7-hydroxymethotrexate and Rheumatic-Diseases

7-hydroxymethotrexate has been researched along with Rheumatic-Diseases* in 2 studies

Other Studies

2 other study(ies) available for 7-hydroxymethotrexate and Rheumatic-Diseases

ArticleYear
Do steroids influence low dose methotrexate pharmacokinetics?
    The Journal of rheumatology, 1994, Volume: 21, Issue:6

    Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; Steroids

1994
Comparison of high-performance liquid chromatography and the Abbott fluorescent polarization radioimmunoassay in the measurement of methotrexate.
    Journal of chromatography, 1989, Sep-29, Volume: 494

    A modified high-performance liquid chromatographic (HPLC) technique for the assay of methotrexate is described and compared to the Abbott Fluorescence Polarization Radioimmunoassay. The reproducibility (coefficient of variation) at low concentrations was similar for the two assays: 8.1 and 8.5% for the Abbott and HPLC assay, respectively. The limit of detection of the two assays was also similar at 0.01 microM. The correlation coefficient for Abbott versus HPLC was 0.9833 with a gradient of 0.9545. Aspirin was the only drug that interfered with HPLC. Methotrexate's metabolite 7-hydroxymethotrexate did not interfere with the Abbott assay. Plasma half-lives were similar to oncology patients in the two rheumatological patients studied. The 7-hydroxymethotrexate half-life was 15 h.

    Topics: Administration, Oral; Aspirin; Chromatography, High Pressure Liquid; Drug Interactions; Fluorescence Polarization; Half-Life; Humans; Indomethacin; Injections, Intravenous; Methotrexate; Radioimmunoassay; Reagent Kits, Diagnostic; Rheumatic Diseases

1989